Skip to main navigation menu Skip to main content Skip to site footer

CLASSIFICATION OF POWDER MEDICINES USED FOR CONSUMPTION

Abstract

Powder meds have for some time been utilized as a compelling method for drug conveyance and utilization. With the progression of drug advancements, many meds are presently accessible in powder structure for both inward and outer applications. Nonetheless, with such an assortment of powder meds on the lookout, it is critical that they are appropriately ordered in view of their expected use, synthesis, and consequences for the human body. This will help customers, clinical experts as well as administrative bodies to all the more likely comprehend, endorse and deal with these plans actually. In this article, I will examine a few vital orders of powder drugs that are regularly utilized for interior utilization.

Keywords

Medicines, processes, powder meds, patient security, classification, preparing system.

DOWNLOAD PDF CERTIFICATE

References

  1. Food and Drug Administration. Guidance for industry, waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Food and Drug Administration, Rockville, MD, 2000. Available at http://www.fda.gov/cder/guidance/index.htm.
  2. World Health Organization. Proposal to waive in vivo bioequivalence requirements for WHO model list of essential medicines immediate-release, solid oral dosage forms. World Health Organization, Technical Report Series no. 937 (2006). Available at http://www.who.int/prequal/info_general/documents/TRS937/WHO_TRS_937__annex8_eng.pdf
  3. Ku M. S. An oral formulation decision tree based on the biopharmaceutical classification system for first in human clinical trials. Bull. Tech. Gattefosse. 2006; 99:89.
  4. J. Baldoni. Role of BCS in drug development. AAPS/FDA workshop on BE, BCS and Beyond, May 21–23, 2007.
  5. Lipiniski C. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997; 23:3–25. doe: 10.1016/S0169-409X (96)00423-1.

Downloads

Download data is not yet available.